Mantra Bio

Mantra Bio is a biotechnology startup founded in 2016 and based in the United States. The company's slogan, "Mantra Bio is harnessing exosomes to deliver safe, highly targeted medicines," reflects its focus on utilizing exosomes for precise drug delivery. Their flagship product, REVEAL™, is an exosome engineering platform that integrates computational biology and lab automation to produce targeted exosome vehicles (TEVs) for various therapeutic areas. Their latest funding round, a $9.00M Series A investment, attracted a consortium of notable investors including BoxGroup, 8VC, Allen & Company, Samsung Securities, Viking Global Investors, and Illumina, demonstrating strong support from prominent players in the industry. Mantra Bio's innovative approach to leveraging exosomes for drug delivery positions the company at the forefront of advancements in the life sciences sector.